newsfilter
← Latest News
Business Wire·

PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights

Announced topline data from Phase 2b clinical trial of bentracimab, which was conducted in healthy, older volunteers 50-80 years old Reached interim enrollment milestone for the REVERSE-IT Phase 3 trial of bentracimab Prespecified interim analysis